Latest News & Articles
Browse all our latest news articles and stories
FAQ on Tesla's Current Challenges and Market Impact
2025 has been a challenging year for Tesla, with declining sales and share prices due to CEO Elon Musk's political involvement and shifting consumer …
FAQ: Gold's 22% Gain in the First 100 Days Since Trump Took Office
Gold prices surged by 22.2% in the first 100 days since Trump's presidency, while the S&P 500 index dropped by over 7%, highlighting gold's strong …
FAQ on Hospitals Exiting Medicare Advantage Plans and Its Impact on Enrollees
When hospitals exit Medicare Advantage (MA) plans due to disagreements with insurers, enrollees often leave the plans as well, facing difficult …
FAQ: Microsoft's Prediction on AI Workers in the Future
FAQ on Authentic Holdings' Acquisition of Goliath Motion Pictures
FAQ on Aditxt Inc.'s ADI-100 Developments and Weekly Update
FAQ on LiveOne's Strategic Exploration Following Napster Sale
LiveOne (Nasdaq: LVO) is exploring strategic alternatives after selling Napster for $207 million, aiming to enhance shareholder value as its current …
FAQ: Micropolis Holding Co. and SEE Holding Ltd Partnership for Sustainable City 2.0
FAQ: Thumzup Media Corp. (NASDAQ: TZUP) Growth and AdTech Platform Expansion
FAQ on Limiting Wastage to Increase Renewable Energy Capacity
FAQ: MasterCard and MetaMask's Revolutionary Crypto Self-Custody Card
MetaMask and MasterCard have partnered to introduce a metal payment card that bridges real-world spending with digital assets, potentially …
FAQ: Understanding the Future Trends in E-Commerce Fulfillment
FAQ on HealthLynked Corp.'s Enhanced Appointment Booking and Patient Empowerment Features
FAQ on New SEC Chair's Promises for Crypto Regulation
FAQ: The Decline of Dating Apps and What It Means for Users and Companies
Dating apps are facing a user decline due to emotional burnout and safety concerns, pushing companies like Momo Inc. to innovate for better user …
Nicola Mining Inc. (TSX.V: NIM) (OTCQB: HUSIF) Investment and Operations FAQ
FAQ on Soligenix Inc.'s HyBryte(TM) and Its Impact on Rare Skin Cancer Treatment
